[Role of starch preparations in the intraoperative correction of hypovolemia in patients with large-size uterine myomas].
The course of anesthesia during uterine extirpation for large and giant myomas depends on the efficiency of blood loss compensation and relative hypovolemia after rapid decompensation when a mass is removed. Thirty-five patients with a uterine myoma with the size corresponding to 18-40-week gestation were examined. Dextrans and voluven (hydroxyethylstarch 130/0.4) were used in Groups 1 (n = 20) and 2 (n = 15). The intraoperative administration of voluven reduced the volume of crystalloids and a need for sympathomimetics and maintained the normal amount of fluid and sectoral distribution.
Valetova
V V
VV
Khudenko
N V
NV
Sakharova
E A
EA
Timerbaev
V Kh
VKh
D000758:Anesthesia; D016063:Blood Loss, Surgical; D000077324:Crystalloid Solutions; D003911:Dextrans / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000627:therapeutic use*; D020896:Hypovolemia / Q000188:drug therapy*; D007431:Intraoperative Complications / Q000188:drug therapy*; D007552:Isotonic Solutions / Q000627:therapeutic use; D007889:Leiomyoma / Q000601:surgery*; D008875:Middle Aged; D013213:Starch / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000601:surgery*; D014599:Uterus / Q000601:surgery*
D000077324:Crystalloid Solutions; D003911:Dextrans; C485123:HES 130-0.4; D006895:Hydroxyethyl Starch Derivatives; D007552:Isotonic Solutions; D013213:Starch